The outcome of thrombotic microangiopathy in kidney transplant recipients
{{output}}
Background: The outcome of kidney transplant recipients with a history of complement-mediated thrombotic microangiopathy (cTMA) and those who develop post-transplant de novo TMA (dnTMA) is largely unknown. ... ...
